In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novare Surgical Systems gets $16mm with its Series D round

Executive Summary

Novare Surgical Systems (minimally invasive surgical devices) has raised $16mm with the sale of Series D preferred shares. Point Judith Capital and Tudor Investment led the round and were joined by current backers Channel Medical Partners, Canaan Partners, Asset Management, and well-known medical device inventor Thomas Fogarty, MD, as well as new investor Deerfield Partners. The company will use the proceeds to begin marketing its RealHand laproscopic instruments. Concurrent with the financing, a member of Point Judith Capital will take a seat on the company's board.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies